Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1970 of 6351
-
Blood test may cut bleeding risk for heart patients on strong meds
Disease control OngoingThe objective of the study is to establish a de-scaling strategy of P2Y12 inhibitors (P2Y12 i) with a decrease in hemorrhagic events without increasing ischemic complications based on a Platelet Function Test (PFT).
Phase 4 • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Blood pressure drug shows promise in cutting heavy drinking
Disease control Recruiting nowThis is a Phase 2 single site randomized clinical trial (RCT) to be supported by a new NIH-NIAAA grant, R01-AA029113-01, to assess the efficacy of Prazosin (16mg/day) versus Placebo over a 12 week treatment period, followed by a 1- and 3- month assessments post-treatment for indi…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New radiation technique aims to calm tremors without surgery
Symptom relief Stopped earlyRadiosurgical thalamotomy on GammaKnife has been shown to be effective in the management of tremors. However, several teams describe a significant risk of severe neurological complications. In addition, fitting the invasive frame and the need to travel to GammKnife centers often …
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can a Low-Carb app help control diabetes?
Disease control CompletedExcess adiposity is a key causal factor in developing type 2 diabetes and weight loss improves glycaemia and can put diabetes in to remission. There is evidence that low carbohydrate diets also reduce glycaemia. The aim of this trial is to test a behavioural support programme del…
Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a targeted nerve block cut opioid use after spine surgery?
Symptom relief CancelledThe goal of this study is to evaluate the analgesic efficacy of bilateral erector spinae plane (ESP) blocks after lumbar and lumbo-sacral spine surgery by assessing postoperative pain scores and opiate requirements as the primary outcome measures. We are aiming to investigate how…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Bionic balance: implant aims to steady patients with inner ear disorder
Disease control OngoingIn the VertiGO! trial 13 participants with bilateral vestibulopathy (BV) and severe sensory neural hearing loss in the ear to be implanted will receive a combined cochlear (CI) and vestibular implant (VI), capable of stimulating both the cochlear and vestibular nerves (CVI). The …
Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Mass malaria treatment aims to protect kids and pregnant women
Disease control CompletedThis is a clinical trial being done to find better ways to reduce malaria in the community. Malaria is caused by a parasite that is spread by mosquitoes. Some people, especially adults, can carry the malaria parasite without feeling sick, but mosquitoes can still pick up the para…
Sponsor: Noguchi Memorial Institute for Medical Research • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
CoviVac vaccine shows promise for seniors in new trial
Vaccine CompletedAn Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) Produced by FSBSI "Chumakov Federal Scientific Center for Research and Developmen…
Phase 2 • Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products • Aim: Vaccine
Last updated Jun 27, 2026 11:02 UTC
-
Shrinking lung tumors before surgery: targeted drugs show promise for rare cancer type
Disease control CompletedThis multicenter retrospective study evaluates preoperative ROS1-TKI therapy in patients with ROS1 fusion-positive locally advanced lung adenocarcinoma. Patients who received ROS1-TKI therapy before surgical resection were retrospectively identified from four tertiary hospitals i…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can High-Tech toothbrushes protect gums in scleroderma?
Symptom relief Stopped earlySystemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximatel…
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can video visits keep HIV patients in care?
Disease control CompletedThe purpose of this research study is to see how effective the addition of video to home telehealth services is in helping patients with HIV to remain in care, which is vital to management of their illness. The investigators also want to understand how to best put the video to ho…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Eye-Tracking training may ease PTSD in veterans
Symptom relief Stopped earlyThe study will examine the efficacy of a feedback-based treatment applying eye-tracking (Gaze-Contingent Music Reward Therapy) to change attention and gaze patterns associated with angry faces relative to a response-time-based attention bias modification treatment applying the do…
Phase 2/3 • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 26, 2026 15:13 UTC
-
New IPF pill enters mid-stage trial – could it slow lung decline?
Disease control OngoingA Phase ll Study to evaluate the efficacy and safety of various doses of HEC585 Tablets in patients with idiopathic pulmonary fibrosis
Phase 2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could an antibody fight both psoriasis and heart disease?
Disease control CompletedThe primary purpose of this proof-of-activity, phase 2 trial is to evaluate the safety and activity of orticumab in subjects with moderate to severe psoriasis and cardiometabolic risk factors.
Phase 2 • Sponsor: Abcentra • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could an immune treatment ease severe OCD in kids with PANS?
Symptom relief CompletedA Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome
Phase 3 • Sponsor: Octapharma • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy aims to stop bone cancer from coming back
Disease control OngoingThe purpose of this study is to test the safety of stereotactic body radiation therapy (SBRT) followed by surgical stabilization within 1 week. All participants will have metastatic cancer in the bone (bone metastases), and they will be at risk of pathologic fracture (broken bone…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a special MRI spot brain lymphoma without a biopsy?
Diagnosis Recruiting nowThis phase I trial evaluates the feasibility of using hyperpolarized carbon C 13 pyruvate magnetic resonance imaging (MRI) in diagnosing patients with primary central nervous system lymphoma. This trial aims to see whether MRI using hyperpolarized carbon-13 pyruvate is safe and u…
Phase 1 • Sponsor: James Rubenstein • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
New combo treatment targets Post-Surgery binge eating
Disease control CompletedThis study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination …
Phase 2/3 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat prostate cancer
Disease control OngoingThis trial is testing whether molecularly targeted oral medications called talazoparib and tazemetostat can be safely combined for the treatment of prostate cancer, and whether the combination is effective in shrinking or preventing the growth of metastatic prostate cancer. The …
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Rabbit-Milk clotting drug tested for hemophilia bleeds
Disease control Recruiting nowPhase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are either on long term prophylactic treatment (e.g., emicizumab) at risk of experiencing a breakthrough bleeding event (BE), …
Phase 4 • Sponsor: American Thrombosis and Hemostasis Network • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC